Opaleye Management as of June 30, 2017
Portfolio Holdings for Opaleye Management
Opaleye Management holds 41 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 18.6 | $45M | 880k | 50.67 | |
| Axogen (AXGN) | 13.8 | $33M | 2.0M | 16.75 | |
| Fibrogen | 4.9 | $12M | 360k | 32.30 | |
| Loxo Oncology | 4.3 | $10M | 130k | 80.19 | |
| Strongbridge Bioph shs usd | 3.5 | $8.4M | 1.2M | 7.15 | |
| Codexis (CDXS) | 3.4 | $8.0M | 1.5M | 5.45 | |
| Immunomedics | 3.3 | $7.9M | 900k | 8.83 | |
| Momenta Pharmaceuticals | 3.2 | $7.6M | 450k | 16.90 | |
| Theravance Biopharma (TBPH) | 3.0 | $7.2M | 180k | 39.84 | |
| Cytomx Therapeutics (CTMX) | 3.0 | $7.1M | 460k | 15.50 | |
| Chimerix (CMRX) | 2.9 | $7.0M | 1.3M | 5.45 | |
| Noveliontherapeuti.. | 2.9 | $6.9M | 750k | 9.23 | |
| Agios Pharmaceuticals (AGIO) | 2.8 | $6.7M | 130k | 51.45 | |
| Corium Intl | 2.2 | $5.3M | 715k | 7.46 | |
| Foamix Pharmaceuticals | 2.2 | $5.3M | 1.1M | 4.64 | |
| Sangamo Biosciences (SGMO) | 2.1 | $5.1M | 580k | 8.80 | |
| Adamas Pharmaceuticals | 2.1 | $5.1M | 290k | 17.49 | |
| Eagle Pharmaceuticals (EGRX) | 2.0 | $4.7M | 60k | 78.88 | |
| Prothena (PRTA) | 1.9 | $4.6M | 85k | 54.12 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $3.6M | 100k | 35.98 | |
| Neuroderm Ltd F | 1.5 | $3.6M | 120k | 29.90 | |
| Acceleron Pharma | 1.3 | $3.0M | 100k | 30.39 | |
| Imprimis Pharmaceuticals | 1.2 | $2.9M | 895k | 3.20 | |
| Audentes Therapeutics | 1.2 | $2.9M | 150k | 19.13 | |
| Ardelyx (ARDX) | 1.2 | $2.8M | 547k | 5.10 | |
| Tetraphase Pharmaceuticals | 1.0 | $2.4M | 330k | 7.13 | |
| Wave Life Sciences (WVE) | 1.0 | $2.3M | 125k | 18.60 | |
| Aratana Therapeutics | 0.9 | $2.3M | 350k | 6.51 | |
| Xoma Corp Del (XOMA) | 0.9 | $2.2M | 317k | 6.99 | |
| Mirna Therapeutics | 0.8 | $1.9M | 1.1M | 1.67 | |
| Syros Pharmaceuticals | 0.7 | $1.8M | 110k | 16.09 | |
| Zosano Pharma | 0.7 | $1.7M | 1.2M | 1.41 | |
| Tonix Pharmaceuticls | 0.7 | $1.6M | 370k | 4.33 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.6 | $1.5M | 1.8M | 0.84 | |
| Edge Therapeutics | 0.6 | $1.3M | 130k | 10.26 | |
| ArQule | 0.5 | $1.2M | 970k | 1.24 | |
| Global Blood Therapeutics In | 0.5 | $1.1M | 40k | 27.35 | |
| Intra Cellular Therapies | 0.4 | $1.1M | 85k | 12.42 | |
| Sunesis Pharmaceuticals Inc Ne | 0.4 | $1.0M | 380k | 2.70 | |
| Neos Therapeutics | 0.1 | $365k | 50k | 7.30 | |
| Biolinerx Ltd-spons | 0.1 | $213k | 250k | 0.85 |
